Table 1:
Baseline Characteristics
| Type 2 | A1 Gestational | A2 Gestational | P | |
|---|---|---|---|---|
| Number | 39 | 28 | 35 | |
| Age | 33 ± 0.87 | 31 ± 0.96 | 31 ± 6.04 | 0.290 |
| BMI at NOB visit | 39 ± 1.31 | 32 ± 1.28 | 38 ± 9.32 | 0.002 |
| HgbA1c at NOB | 7.6 ± 0.27 | 5.3 ± 0.091 | 5.3 ± 0.342 | <0.001 |
| Nulliparous (Y/N) | 8 (21%) | 7 (25%) | 13 (37%) | 0.262 |
| Medicaid (Y/N) | 31 (80%) | 11 (39%) | 17 (49%) | 0.002 |
| Gestational age at first contact (weeks) | 17 ± 0.97 | 29 ± 3.90 | 27 ± 4.70 | <0.001 |
| Weeks of glucose testing | 20.22 ± 1.11 | 9.20 ± 4.31 | 10.31 ± 5.27 | <0.001 |
| Medication:Insulin | 33 (85%) | N/A | 22 (63%) | <0.001 |
| Medication:Metformin | 1 (3%) | N/A | 2 (6%) | * |
| Medication:Glyburide | 4 (10%) | N/A | 11 (31%) | * |
| GA at delivery (wks) | 36.87 ± 0.58 | 37.96 ± 2.10 | 37.51 ± 2.02 | 0.270 |
| HgbA1c % at delivery | 6.3 ± 0.18 | 5.1 ± 0.103 | 5.4 ± 0.074 | <0.001 |
| Birthweight (gms) | 3235 ± 162 | 3069 ± 137 | 3239 ± 110 | 0.657 |
| Preeclampsia | 7 (18%) | 3 (11%) | 8 (23%) | * |
| Cesarean delivery | 21 (54%) | 13 (46%) | 18 (51%) | 0.834 |
| Primary Cesarean delivery | 7 (33%) | 6 (46%) | 8 (44%) | * |
| Hypoglycemia | 22 (61%) | 12 (43%) | 20 (57%) | 0.322 |
| Large for Gestational Age | 11 (28%) | 2 (7%) | 5 (14%) | * |
Data are expressed as mean ± SE or n (%). P values are for One-way ANOVA or Chi-Square as appropriate.
1
Missing data for 1 participant (n=27)
2
Missing data for 3 participants (n=32)
3
Missing data for 10 participants (n=18)
4
Missing data for 13 participants (n=22)
*
Data violate Chi-square minimum expected counts assumption.